Tumor-based screening for hereditary nonpolyposis colorectal cancer: does age-based selection optimize yield?
作者信息
Lynch Patrick M
出版信息
J Oncol Pract. 2013 Jul;9(4):180-1. doi: 10.1200/JOP.2012.000786. Epub 2013 Apr 2.
Abstract
摘要
相似文献
1
Tumor-based screening for hereditary nonpolyposis colorectal cancer: does age-based selection optimize yield?
J Oncol Pract. 2013 Jul;9(4):180-1. doi: 10.1200/JOP.2012.000786. Epub 2013 Apr 2.
2
Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.
Dis Colon Rectum. 2006 Jan;49(1):80-93; discussion 94-5. doi: 10.1007/s10350-005-0228-0.
3
Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Dis Colon Rectum. 2003 Mar;46(3):305-12. doi: 10.1007/s10350-004-6546-9.
4
Family matters in lynch syndrome.
J Natl Cancer Inst. 2015 Mar 20;107(4). doi: 10.1093/jnci/djv050. Print 2015 Apr.
5
Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients.
Dis Colon Rectum. 1999 Jan;42(1):36-42. doi: 10.1007/BF02235180.
6
Screening modalities in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.
Gastrointest Endosc Clin N Am. 1997 Jan;7(1):81-6.
7
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.
Dis Colon Rectum. 2002 Dec;45(12):1588-94. doi: 10.1007/s10350-004-7244-3.
8
Immunohistochemistry in screening for heritable colorectal cancer: what to do with an abnormal result.
ANZ J Surg. 2020 May;90(5):702-707. doi: 10.1111/ans.15586. Epub 2019 Dec 11.
9
Re: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
J Natl Cancer Inst. 2004 Sep 15;96(18):1402-3; author reply 1403-4. doi: 10.1093/jnci/djh280.
10
Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
Dis Colon Rectum. 2020 Feb;63(2):152-159. doi: 10.1097/DCR.0000000000001550.
本文引用的文献
1
Impact of age cutoffs on a lynch syndrome screening program.
J Oncol Pract. 2013 Jul;9(4):175-9. doi: 10.1200/JOP.2012.000573. Epub 2012 Nov 13.
2
Identification of Lynch syndrome among patients with colorectal cancer.
JAMA. 2012 Oct 17;308(15):1555-65. doi: 10.1001/jama.2012.13088.
3
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
J Clin Oncol. 2011 Jul 10;29(20):2773-80. doi: 10.1200/JCO.2010.34.4911. Epub 2011 May 23.
4
Microsatellite instability in colorectal cancer.
Gastroenterology. 2010 Jun;138(6):2073-2087.e3. doi: 10.1053/j.gastro.2009.12.064.
5
NCCN clinical practice guidelines in oncology. Colorectal cancer screening.
J Natl Compr Canc Netw. 2010 Jan;8(1):8-61. doi: 10.6004/jnccn.2010.0003.
6
Management of extracolonic tumours in patients with Lynch syndrome.
Lancet Oncol. 2009 Apr;10(4):400-8. doi: 10.1016/S1470-2045(09)70041-5.
7
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Genet Med. 2009 Jan;11(1):42-65. doi: 10.1097/GIM.0b013e31818fa2db.
8
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff.
9
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Gut. 2006 Dec;55(12):1819-20. doi: 10.1136/gut.2006.105627.
10
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
N Engl J Med. 2005 May 5;352(18):1851-60. doi: 10.1056/NEJMoa043146.
Zotero 插件